Market open
Harrow Health/$HROW
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Harrow Health
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.
Ticker
$HROW
Sector
Trading on
Industry
Pharmaceuticals
Headquarters
Employees
382
ISIN
US4158581094
Website
Harrow Health Metrics
BasicAdvanced
$922M
-
-$0.61
0.41
-
Price and volume
Market cap
$922M
Beta
0.41
52-week high
$56.01
52-week low
$15.78
Average daily volume
487K
Financial strength
Current ratio
0.907
Quick ratio
0.789
Long term debt to equity
215.848
Total debt to equity
215.848
Interest coverage (TTM)
0.20%
Management effectiveness
Return on assets (TTM)
0.90%
Return on equity (TTM)
-37.31%
Valuation
Price to revenue (TTM)
4.219
Price to book
15.97
Price to tangible book (TTM)
15.97
Price to free cash flow (TTM)
-24.407
Growth
Revenue change (TTM)
53.49%
Earnings per share change (TTM)
-34.30%
3-year revenue growth (CAGR)
39.06%
3-year earnings per share growth (CAGR)
-8.16%
What the Analysts think about Harrow Health
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Harrow Health stock.
Harrow Health Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Harrow Health Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Harrow Health News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Harrow Health stock?
Harrow Health (HROW) has a market cap of $922M as of May 15, 2025.
What is the P/E ratio for Harrow Health stock?
The price to earnings (P/E) ratio for Harrow Health (HROW) stock is 0 as of May 15, 2025.
Does Harrow Health stock pay dividends?
No, Harrow Health (HROW) stock does not pay dividends to its shareholders as of May 15, 2025.
When is the next Harrow Health dividend payment date?
Harrow Health (HROW) stock does not pay dividends to its shareholders.
What is the beta indicator for Harrow Health?
Harrow Health (HROW) has a beta rating of 0.41. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.